The expression and purification of the N-terminal activation domain of the transcription factor c-Myc: A model substrate for exploring ERK2 docking interactions

Protein Expression and Purification

Volumn 53, Issue 1, 2007, Pages 80-86

  Waas, William F ^a   Dalby, Kevin N ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

c Myc; ERK2; MAPK kinase

Indexed keywords

GLUTATHIONE TRANSFERASE; HISTIDINE; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; PEPTIDE FRAGMENT; SERINE; THROMBIN;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME SPECIFICITY; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFORMATION; GENETICS; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN TERTIARY STRUCTURE; TIME;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GENE EXPRESSION; GLUTATHIONE TRANSFERASE; HISTIDINE; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT FUSION PROTEINS; SERINE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTRATE SPECIFICITY; THROMBIN; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMATION, GENETIC;

ESCHERICHIA COLI;

EID: 33847174499     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.12.004     Document Type: Article

References (31)

1. Tanoue T., and Nishida E. Docking interactions in the mitogen-activated protein kinase cascades. Pharmacol. Ther. 93 (2002) 193-202
2. Rainey M.A., Callaway K., Barnes R., Wilson B., and Dalby K.N. Proximity-induced catalysis by the protein kinase ERK2. J. Am. Chem. Soc. 127 (2005) 10494-10495
3. Gonzalez F.A., Raden D.L., and Davis R.J. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266 (1991) 22159-22163
4. Waas W.F., and Dalby K.N. Purification of a model substrate for transcription factor phosphorylation by ERK2. Protein Expr. Purif. 23 (2001) 191-197
5. Hawkins J., Zheng S., Frantz B., and LoGrasso P. p38 map kinase substrate specificity differs greatly for protein and peptide substrates. Arch. Biochem. Biophys. 382 (2000) 310-313
6. Sharrocks A.D., Yang S.H., and Galanis A. Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem. Sci. 25 (2000) 448-453
7. Jacobs D., Glossip D., Xing H., Muslin A.J., and Kornfeld K. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev. 13 (1999) 163-175
8. Fantz D.A., Jacobs D., Glossip D., and Kornfeld K. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues. J. Biol. Chem. 276 (2001) 27256-27265
9. Callaway K., Rainey M.A., Riggs A., and Dalby K.N. Properties and regulation of a transiently assembled ERK2-Ets-1 signaling complex. Biochemistry 45 (2006) 13719-13733
10. Liu S., Sun J.P., Zhou B., and Zhang Z.Y. Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. Proc. Natl. Acad. Sci. USA 103 (2006) 5326-5331
11. Chang C.I., Xu B.E., Akella R., Cobb M.H., and Goldsmith E.J. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell 9 (2002) 1241-1249
12. Heo Y.S., Kim S.K., Seo C.I., Kim Y.K., Sung B.J., Lee H.S., Lee J.I., Park S.Y., Kim J.H., Hwang K.Y., Hyun Y.L., Jeon Y.H., Ro S., Cho J.M., Lee T.G., and Yang C.H. Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. Embo. J. 23 (2004) 2185-2195
13. Remenyi A., Good M.C., Bhattacharyya R.P., and Lim W.A. The role of docking interactions in mediating signaling input, output, and discrimination in the yeast MAPK network. Mol. Cell 20 (2005) 951-962
14. Lee T., Hoofnagle A.N., Kabuyama Y., Stroud J., Min X., Goldsmith E.J., Chen L., Resing K.A., and Ahn N.G. Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. Mol. Cell 14 (2004) 43-55
15. Pelengaris S., Khan M., and Evan G. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer 2 (2002) 764-776
16. Pelengaris S., and Khan M. The many faces of c-MYC. Arch. Biochem. Biophys. 416 (2003) 129-136
17. Schmidt E.V. The role of c-myc in regulation of translation initiation. Oncogene 23 (2004) 3217-3221
18. Wade M., and Wahl G.M. c-Myc, genome instability, and tumorigenesis: the devil is in the details. Curr. Top. Microbiol. Immunol. 302 (2006) 169-203
19. Ferrer I., Blanco R., Carmona M., and Puig B. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Neuropathol. Appl. Neurobiol. 27 (2001) 343-351
20. Sears R.C. The life cycle of C-myc: from synthesis to degradation. Cell Cycle 3 (2004) 1133-1137
21. Sears R., Nuckolls F., Haura E., Taya Y., Tamai K., and Nevins J.R. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14 (2000) 2501-2514
22. Gupta S., and Davis R.J. MAP kinase binds to the NH2-terminal activation domain of c-Myc. FEBS Lett. 353 (1994) 281-285
23. Waas W.F., Rainey M.A., Szafranska A.E., and Dalby K.N. Two rate-limiting steps in the kinetic mechanism of the serine/threonine specific protein kinase ERK2: a case of fast phosphorylation followed by fast product release. Biochemistry 42 (2003) 12273-12286
24. Lutterbach B., and Hann S.R. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol. Cell Biol. 14 (1994) 5510-5522
25. Kemp B.E., Benjamini E., and Krebs E.G. Synthetic hexapeptide substrates and inhibitors of 3′:5′-cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 73 (1976) 1038-1042
26. Gill S.C., and von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182 (1989) 319-326
27. Seidel J.J., and Graves B.J. An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev. 16 (2002) 127-137
28. Prowse C.N., and Lew J. Mechanism of activation of ERK2 by dual phosphorylation. J. Biol. Chem. 276 (2001) 99-103
29. Prowse C.N., Deal M.S., and Lew J. The complete pathway for catalytic activation of the mitogen-activated protein kinase, ERK2. J. Biol. Chem. 276 (2001) 40817-40823
30. Murphy L.O., MacKeigan J.P., and Blenis J. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol. Cell Biol. 24 (2004) 144-153
31. Murphy L.O., and Blenis J. MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31 (2006) 268-275